BURONI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 3.847
AS - Asia 2.662
EU - Europa 2.145
SA - Sud America 421
Continente sconosciuto - Info sul continente non disponibili 183
AF - Africa 116
OC - Oceania 15
AN - Antartide 1
Totale 9.390
Nazione #
US - Stati Uniti d'America 3.722
CN - Cina 1.208
SG - Singapore 576
IE - Irlanda 493
BR - Brasile 316
HK - Hong Kong 307
RU - Federazione Russa 269
DE - Germania 253
VN - Vietnam 237
IT - Italia 216
UA - Ucraina 213
FI - Finlandia 199
FR - Francia 137
GB - Regno Unito 127
SE - Svezia 105
IN - India 70
CA - Canada 65
ZA - Sudafrica 57
BD - Bangladesh 54
AR - Argentina 40
JP - Giappone 32
MX - Messico 31
IQ - Iraq 26
PL - Polonia 23
JO - Giordania 22
ES - Italia 20
CO - Colombia 18
TR - Turchia 18
ID - Indonesia 16
BE - Belgio 14
EC - Ecuador 13
AU - Australia 12
LT - Lituania 12
AZ - Azerbaigian 11
CZ - Repubblica Ceca 11
EG - Egitto 11
NL - Olanda 11
AT - Austria 10
PK - Pakistan 10
UZ - Uzbekistan 10
CL - Cile 9
MA - Marocco 9
NG - Nigeria 9
JM - Giamaica 7
PH - Filippine 7
VE - Venezuela 7
BO - Bolivia 6
CR - Costa Rica 6
GR - Grecia 6
KG - Kirghizistan 6
PY - Paraguay 6
SA - Arabia Saudita 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
DO - Repubblica Dominicana 5
KE - Kenya 5
MU - Mauritius 5
MY - Malesia 5
NP - Nepal 5
PE - Perù 5
TH - Thailandia 5
CH - Svizzera 4
HU - Ungheria 4
IL - Israele 4
PA - Panama 4
ET - Etiopia 3
GT - Guatemala 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BH - Bahrain 2
CG - Congo 2
DK - Danimarca 2
DZ - Algeria 2
EU - Europa 2
IR - Iran 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
MD - Moldavia 2
RO - Romania 2
RS - Serbia 2
ZM - Zambia 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
GH - Ghana 1
GM - Gambi 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HN - Honduras 1
HR - Croazia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MM - Myanmar 1
NI - Nicaragua 1
Totale 9.202
Città #
Chandler 489
Dublin 485
San Jose 385
Ashburn 374
Singapore 329
Hong Kong 303
Beijing 298
Dallas 257
Jacksonville 256
Nanjing 194
Boardman 144
Council Bluffs 126
Los Angeles 98
Ho Chi Minh City 91
Helsinki 86
Lauterbourg 85
Princeton 80
Lawrence 75
Pavia 69
Nanchang 68
Wilmington 68
Medford 64
Ann Arbor 63
Jiaxing 63
New York 63
Munich 61
Shenyang 59
Hanoi 58
Shanghai 56
Changsha 55
Hebei 53
Johannesburg 51
Moscow 46
Santa Clara 43
Hangzhou 42
Buffalo 40
Milan 34
Tianjin 33
Tokyo 29
Redondo Beach 28
São Paulo 28
Frankfurt am Main 26
The Dalles 22
Woodbridge 22
Amman 21
Brooklyn 21
Denver 21
Orem 21
San Francisco 21
London 18
Turku 18
Warsaw 18
Columbus 17
Montreal 17
Houston 16
Toronto 16
Norwalk 15
Stockholm 15
Chicago 14
Da Nang 14
Phoenix 14
Boston 13
Brussels 13
Mexico City 13
Poplar 13
Verona 13
Mumbai 12
Ottawa 12
Seattle 12
Washington 12
Baku 11
Brasília 11
Falkenstein 11
Rio de Janeiro 11
Rome 11
Atlanta 10
Baghdad 10
Falls Church 10
Nuremberg 10
Olomouc 10
Porto Alegre 10
Tashkent 10
Fairfield 9
Haiphong 9
Hyderabad 9
Hải Dương 9
Lagos 9
Manchester 9
Piscataway 9
Chennai 8
Redwood City 8
Vienna 8
Des Moines 7
St Petersburg 7
Belo Horizonte 6
Bishkek 6
Can Tho 6
Curitiba 6
Florence 6
Guangzhou 6
Totale 6.071
Nome #
Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β-d-ribofuranose 2'-Oxidase DprE1. 181
Biological and structural characterization of theMycobacterium smegmatis nitroreductase NfnB, and its rolein benzothiazinone resistance 167
Antistaphylococcal activity of the ftsz inhibitor c109 167
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis 160
Bactericidal and Anti-Biofilm Activity of the FtsZ Inhibitor C109 against Acinetobacter baumannii 155
Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance 153
Analyzing the role of RND efflux transporters in Burkholderia cenocepacia: a proteomic analysis. 153
Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome 152
A census of RND superfamily proteins in the Burkholderia genus. 151
Investigating the Mechanism of Action of Diketopiperazines Inhibitors of the Burkholderia cenocepacia Quorum Sensing Synthase CepI: A Site-Directed Mutagenesis Study 148
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis 146
Decaprenylphosphoryl-β-D-ribose 2’-epimerase from Mycobacterium tuberculosis is a magic drug target 144
Differential role of RND efflux pumps in antimicrobial drug resistance of sessile and planktonic Burkholderia cenocepacia cells 143
Characterization of the mechanism of resistance to BM212, a new potential antitubercular drug. 135
Biochemical Characterization of Glutamate Racemase-A New Candidate Drug Target against Burkholderia cenocepacia Infections 134
Decaprenylphosphoryl-beta-D-ribose 2’-epimerase from Mycobacterium tuberculosis is a magic drug target. 133
Bombas de eflujo como trasportadores de membrana implicados en resistencia a antibióticos en micobacterias 133
Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis. 132
Identification and characterization of the cellular target for benzothiazinones, a new potential antitubercular drug class. 131
Discovery of new diketopiperazines inhibiting Burkholderia cenocepacia quorum sensing in vitro and in vivo. 131
Chemical, Metabolic, and Cellular Characterization of a FtsZ Inhibitor Effective Against Burkholderia cenocepacia 131
Rv2466c mediates the activation of TP053 to kill replicating and non-replicating Mycobacterium tuberculosis. 130
Mycobacterium tuberculosis Phosphoribosylpyrophosphate Synthetase: Biochemical Features of a Crucial Enzyme for Mycobacterial Cell Wall Biosynthesis. 129
Phenotypic and Genotypic Characterisation of Burkholderia cenocepacia J2315 Mutants Affected in Homoserine Lactone and Diffusible Signal Factor-Based Quorum Sensing Systems Suggests Interplay between Both Types of Systems. 126
LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis 123
LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis. 123
Molecular characterization of the burkholderia cenocepacia dcw operon and ftsz interactors as new targets for novel antimicrobial design 123
Study of the regulation of lfrA gene coding for an antibiotic efflux pump of Mycobacterium smegmatis. 122
Espressione, purificazione ed analisi funzionale della NAD+ sintetasi di Mycobacterium tuberculosis, un enzima essenziale 121
Mechanism of resistance to an antitubercular 2-thiopyridine derivative that is also active against Burkholderia cenocepacia. 121
Contribution of the Mycobacterium tuberculosis efflux pumps to drug resistance 120
MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212 119
Efflux-mediated resistance to a benzothiadiazol derivative effective against Burkholderia cenocepacia 119
Burkholderia cenocepacia infections in cystic fibrosis patients: Drug resistance and therapeutic approaches 118
Competitive fitness of essential gene knockdowns reveals a broad-spectrum antibacterial inhibitor of the cell division protein FtsZ 117
A new promising bactericidal compound against Burkholderia cenocepacia. 116
Antimicrobial activity of six essential oils against Burkholderia cepacia complex: Insights into mechanism(s) of action 115
The MmpL3 protein is responsible for resistance to BM212, a lead antitubercular drug. 114
Studies on the identification and characterization of the cellular target of the potential antitubercular drug BM212. 113
Mycobacterium tuberculosis: drug resistance and future perspectives 112
The cell division protein FtsZ as a cellular target to hit cystic fibrosis pathogens 112
Role in benzothiazinone resistance of nitroreductase NfnB of Mycobacterium smegmatis 111
AI is a viable alternative to high throughput screening: a 318-target study 110
Structural plasticity and distinct drug-binding modes of LfrR, a mycobacterial efflux pump regulator. 110
CodY Is a Global Transcriptional Regulator Required for Virulence in Group B Streptococcus 110
Deciphering the role of RND efflux transporters in Burkholderia cenocepacia. 109
Methodological tools to study species of the genus Burkholderia 109
Identification of the cellular target of the potential antitubercular drug BM 212 108
Design of Anti-infectious Agents from Lawsone in a Three-Component Reaction with Aldehydes and Isocyanides 106
Characterization of the dispirotripiperazine derivative PDSTP as antibiotic adjuvant and antivirulence compound against Pseudomonas aeruginosa 104
The crystal structure of Burkholderia cenocepacia DfsA provides insights into substrate recognition and quorum sensing fatty acid biosynthesis 101
Role of rnd efflux pumps in drug resistance of cystic fibrosis pathogens 101
Rv3790 is the cellular target for benzothiazinones, a new promising antitubercular drug class 100
Antivirulence compounds: a future direction to overcome antibiotic resistance? 100
Glutamine amidotransferase activity of NAD+ synthetase from Mycobacterium tuberculosis depends on an amino-terminal nitrilase domain. 97
Fighting against resistant strains: the case of benzothiazinones and dinitrobenzamides 94
The Evolution of Antimicrobial Resistance in Acinetobacter baumannii and New Strategies to Fight It 92
Study of antibiotic efflux pumps belonging to Resistance-Nodulation-Division (RND) family in Burkholderia cenocepacia. 90
Deciphering the Role of RND Efflux Transporters in Burkholderia cenocepacia. 88
Vaccines to Overcome Antibiotic Resistance: The Challenge of Burkholderia cenocepacia 88
Identification of a New FtsZ Inhibitor by Virtual Screening, Mechanistic Insights, and Structure-Activity Relationship Analyses 88
The role of RND efflux transporters in intrinsic antibiotic resistance of Burkholderia cenocepacia 87
Molecular basis for antibiotic resistance in the genus Burkholderia 87
Antibiotics sustainability: another issue in the fight against antimicrobial resistance. 87
Exploring the HME and HAE1 efflux systems in the genus Burkholderia 86
Identification by Reverse Vaccinology of Three Virulence Factors in Burkholderia cenocepacia That May Represent Ideal Vaccine Antigens 85
Quorum sensing as antivirulence target in cystic fibrosis pathogens 84
Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa MDR clinical isolates. 83
Recent advances to combat ESKAPE pathogens with special reference to essential oils 79
New antivirulence compounds affecting Burkholderia cenocepacia quorum sensing in vitro and in vivo. 76
The novel drug candidate VOMG kills Mycobacterium abscessus and other pathogens by inhibiting cell division. 74
Mycobacterium tuberculosis efflux pumps: an update 74
Illumina-based chemogenomic profiling of a novel compound with antimicrobial activity reveals its role as a cell division inhibitor. 73
New Antimicrobial Strategies to Treat Multi-Drug Resistant Infections Caused by Gram-Negatives in Cystic Fibrosis 72
Molecular Mechanisms of Chlorhexidine Tolerance in Burkholderia cenocepacia Biofilms. 70
PEGylated mucus-penetrating nanocrystals for lung delivery of a new FtsZ inhibitor against Burkholderia cenocepacia infection 70
THERAPEUTIC STRATEGIES TO COMBAT STAPHYLOCOCCUS AUREUS INFECTIONS IN CYSTIC FIBROSIS 67
Structural plasticity and distinct drug-binding modes of LfrR, a mycobacterial efflux pump regulator. 66
The role of RND efflux transporters in Burkholderia cenocepacia life. 66
Various evolutionary trajectories lead to loss of the tobramycin-potentiating activity of the quorum sensing inhibitor baicalin hydrate in Burkholderia cenocepacia biofilms 66
The Effect of 2-Thiocyanatopyridine Derivative 11026103 on Burkholderia Cenocepacia: Resistance Mechanisms and Systemic Impact 65
Phenylacetyl-CoA, not phenylacetic acid, attenuates CepIR-regulated virulence in Burkholderia cenocepacia 60
Subfunctionalization influences the expansion of bacterial multidrug antibiotic resistance 54
Editorial: Community series in insights into new strategies to combat biofilms, volume II 48
Lessons from Vibrio Pathogen and the Comparative Study of Vaccines Developed 46
Editorial: Insights Into New Strategies to Combat Biofilms 42
Editorial: Burkholderia spp.-transmission, pathogenesis, host-pathogen interaction, prevention and treatment 39
Editorial: Evolution of Genetic Mechanisms of Antibiotic Resistance 34
Liposomal tobramycin and ceftazidime as advanced nanocarriers against Pseudomonas aeruginosa infections 31
Synthesis, structural characterization, and biological evaluation of cinnamaldehyde–azomethine hybrids: In Vitro and In Silico approaches 30
Totale 9.390
Categoria #
all - tutte 38.458
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.458


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022355 0 5 1 17 11 12 9 20 18 11 57 194
2022/20231.329 127 113 12 125 126 119 12 83 557 7 29 19
2023/2024569 62 89 19 30 40 119 26 60 5 40 46 33
2024/20251.533 23 101 44 32 64 87 116 94 384 65 196 327
2025/20263.534 301 201 406 389 498 153 617 155 334 236 156 88
2026/2027183 60 123 0 0 0 0 0 0 0 0 0 0
Totale 9.390